In decomposition-based multiobjective evolutionary algorithms, the setting of search directions (or weight vectors), and the choice of reference points (i.e., the ideal point or the nadir point) in scalarizing functions, are of great importance to the performance of the algorithms. This paper proposes a new decomposition-based many-objective optimizer by simultaneously using adaptive search directions and two reference points. For each parent, binary search directions are constructed by using its objective vector and the two reference points. Each individual is simultaneously evaluated on two fitness functions-which are motivated by scalar projections-that are deduced to be the differences between two penalty-based boundary intersection (PBI) functions, and two inverted PBI functions, respectively. Solutions with the best value on each fitness function are emphasized. Moreover, an angle-based elimination procedure is adopted to select diversified solutions for the next generation. The use of adaptive search directions aims at effectively handling problems with irregular Pareto-optimal fronts, and the philosophy of using the ideal and nadir points simultaneously is to take advantages of the complementary effects of the two points when handling problems with either concave or convex fronts. The performance of the proposed algorithm is compared with seven state-of-the-art multi-/many-objective evolutionary algorithms on 32 test problems with up to 15 objectives. It is shown by the experimental results that the proposed algorithm is flexible when handling problems with different types of Pareto-optimal fronts, obtaining promising results regarding both the quality of the returned solution set and the efficiency of the new algorithm.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCYB.2018.2819360DOI Listing

Publication Analysis

Top Keywords

search directions
16
reference points
12
handling problems
12
evolutionary algorithms
8
adaptive search
8
pbi functions
8
pareto-optimal fronts
8
proposed algorithm
8
problems
5
points
5

Similar Publications

A patent review of xanthine oxidase inhibitors (2021-present).

Expert Opin Ther Pat

December 2024

Key Laboratory of Structure-Based Drugs Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang, China.

Introduction: Xanthine oxidase (XO) catalyzes the oxidation of both hypoxanthine and xanthine in the last two steps of the purine metabolic pathway, serving as a rate-limiting enzyme for uric acid production as well as a key target for the treatment of gout and other hyperuricemia-related conditions.

Areas Covered: This paper reviews XO inhibitors in patents from 2021 to the present. We summarize in detail the structural classes and characteristics, in vitro and in vivo biological results, and structure‒activity relationships of synthetic inhibitors, as well as the sources, specific structures, research methods, and biological activities of XO inhibitors from natural products.

View Article and Find Full Text PDF

The trend of an annual increase in the detection of new cases of osteoarthritis (OA) and an increase in the number of patients with chronic lower back pain (LBP) calls for the search for new drugs and pharmaconutraceuticals with anti-inflammatory and chondroprotective properties. In 2019, approaches to the treatment of pain in OA significantly changed. In international and Russian clinical guidelines (CG), pharmaconutraceutical chondroitin sulfate (CS) and glucosamine sulfate (GS) are recommended for OA of different localization as a basic therapy.

View Article and Find Full Text PDF

Background: Competency-Based Medical Education (CBME) aims to align educational outcomes with the demands of modern healthcare. Entrustable Professional Activities (EPAs) serve as key tools for feedback and professional development within CBME. With the growing body of literature on EPAs, there is a need to synthesize existing research on stakeholders' experiences and perceptions to enhance understanding of the implementation and impact of EPAs.

View Article and Find Full Text PDF

Background: Acute Heart Failure (AHF) presents as a serious pathophysiological disease with significant morbidity and mortality rates, requiring immediate medical intervention. Traditional treatment involves diuretics and vasodilators, but a subset of patients develop resistance due to acute cardiorenal syndrome. Dapagliflozin, categorized as a sodium-glucose cotransporter-2 inhibitor (SGLT2i), has emerged as a promising therapy for AHF, demonstrating substantial benefits in reducing both mortality and morbidity among patients.

View Article and Find Full Text PDF

Contamination of water by heavy toxic metal ions such as (e.g., Cr, Mn, Ni, Cu, Zn, As Pb, Cd, and Ag) can lead to serious environmental and human health problems because of their acute and chronic toxicity to the biological system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!